Pharmaceutical Executive-07-01-2005

Pharmaceutical Executive

Playing Doctor

July 01, 2005

From the Editor

0

0

If congressmen gathered to work through the nuances of banning ED drugs from reimbursement under Medicare, they'd still back the ban. But the decision would be grounded in lack of faith in prescribing behavior, not disregard for a debilitating condition.

Playing Doctor

July 01, 2005

From the Editor

0

0

If congressmen gathered to work through the nuances of banning ED drugs from reimbursement under Medicare, they'd still back the ban. But the decision would be grounded in lack of faith in prescribing behavior, not disregard for a debilitating condition.

Leadership: Not Braver. . . Boulder

July 01, 2005

Columns

0

0

We all remember the Greek myth about old King Sisyphus. In life, he was a trickster, but the gods got the last laugh in the afterlife by making it his fate to push a huge boulder up a mountain only to see it roll down just before reaching the summit-again and again for all eternity.

TOC

July 01, 2005

TOC

0

0

What Pharma Wants From IT Today

Thought Leader: Getting "Sirius" About Specialty

July 01, 2005

Columns

0

0

Garry Barnes says he joined the pharma industry for job security-but don't believe him. During the last 25 years, Barnes has worked for four pharma companies and built five sales forces in therapeutic areas ranging from contraception to organ transplantation.

Legal Forum: Loss Causation

July 01, 2005

Columns

0

0

Plantiffs did not try to establish a link between the purported misconduct and the decline in share price. Rather, their sole allegation was that they had paid artificially inflated prices for Dura securities.

Informatics Rules

July 01, 2005

Features

0

0

Without common reporting standards in place, researchers have little incentive to share data with scientists elsewhere in the company. When researchers don't sharedata on a regular basis, they can begin to feel proprietary about their work-and even less inclined to disclose their results.

Shedding Wings

July 01, 2005

Features

0

0

It's an open question whether a pharmaceutical company really needs to have the drug testing process inside its corporate walls, or whether they really should be focusing much more on building effective relationships, in terms of building awareness and acceptance of their products, with both the physicians and end consumers.

Washington Report: The e-Bandwagon

July 01, 2005

Columns

0

0

Pharma companies believe that they can compete in an e-prescribing environment if information systems permit full disclosure and allow doctors to create bookmarks that link easily to information they want.

Informatics Rules

July 01, 2005

Features

0

0

Without common reporting standards in place, researchers have little incentive to share data with scientists elsewhere in the company. When researchers don't sharedata on a regular basis, they can begin to feel proprietary about their work-and even less inclined to disclose their results.

Up in Smoke

July 01, 2005

Columns

0

0

Accept distortions and untruths. Don't try to undo them. The point is not to win an argument; your critics' views are legitimate, irreversible realities. It's time to give the public something new to think about.